Analysts: Boeing Is Inexpensive and 3 Other Research Notes to Browse
The Boeing Company (NYSE:BA): Bernstein has raised Boeing’s price target to $146 from $127. The firm believes that Boeing’s shares are still inexpensive on most metrics, and that Boeing has several upcoming catalysts and low risk, with the 787′s costs on track. It has kept an Outperform rating on Boeing’s stock.
Questcor Pharmaceuticals (NASDAQ:QCOR): Piper Jaffray has said that the recent weakness in shares of Questcor presents an attractive buying opportunity, and has reiterated its Overweight rating on Questcor’s stock with a $74 price target. Piper also said that most major managed care organizations continue to reimburse Questcore for its Acthar medicine.
Celgene Corporation (NASDAQ:CELG): Leerink has raised its price target for Celgene shares to $177 from $165 after meeting with management, and has maintained an Outperform rating on Celgene’s stock. The firm said it left the meeting with increased conviction in Celgene’s near- and long-term growth potential.
CarMax (NYSE:KMX): Goldman has downgraded CarMax to Neutral from Buy due to valuation and credit headwinds. The analyst said that data from recent securitizations indicates that credit profits are set to decline in 2014. The firm has raised CarMax’s price target to $55 from $53.